You have 9 free searches left this month | for more free features.

City

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

OncoNano Medicine, Inc. (1)

Collaborator

Intervention

cemiplimab (1)

onm-501 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

onm-501

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting

Triple Negative Breast Cancer
+13 more

ONM-501
Cemiplimab

(no location specified)

Aug 29, 2023